To Assess The Patient Preference for Goserelin Microsphere Versus Goserelin Implant in Patients With Prostate Cancer - Trial NCT06385847
Access comprehensive clinical trial information for NCT06385847 through Pure Global AI's free database. This Phase 2 trial is sponsored by The First Affiliated Hospital of Xiamen University and is currently Recruiting. The study focuses on Prostate Cancer. Target enrollment is 60 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
The First Affiliated Hospital of Xiamen University
Timeline & Enrollment
Phase 2
May 01, 2024
Dec 01, 2025
Primary Outcome
Patient preference
Summary
The GOMIMP will be a Prospective, Randomized, Cross-over Trial to Explore the Patient
 Preference for Goserelin Microsphere (Zoladex®) Versus Goserelin Implant (LY01005) in
 Patients of Prostate Cancer
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06385847
Non-Device Trial